Every 10-Q that Superior Group of Companies, Inc. (SGC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SGC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SGC filings page.
Superior Group of Companies reported Q2 2026 net sales of $147.8 million, up 2.6% year over year, while net income fell to $1.2 million from $1.6 million, or $0.08 per diluted share. A $2.6 million trade name impairment and a $2.6 million additional inventory write-down in the Healthcare Apparel segment weighed on results, partly offset by net tariff refunds.
For the first six months of 2026, net sales were $288.7 million and net income rose to $2.1 million from $0.8 million, with Adjusted EBITDA increasing to $12.5 million. Branded Products delivered higher revenue and margins, while Contact Centers saw lower sales but reduced credit loss expense. Operating cash flow strengthened sharply to $17.7 million, inventories and total debt declined, and shareholders received $0.28 per share in dividends alongside modest share repurchases, leaving equity at $193.4 million.
Superior Group of Companies reported Q1 2026 results showing a return to profitability and stronger cash generation. Net sales for the three months ended March 31, 2026 were $140.9 million, up 2.8% from $137.1 million a year earlier, driven by growth in Branded Products and Healthcare Apparel.
The company generated net income of $0.8 million versus a loss of $0.8 million in Q1 2025, with diluted EPS of $0.06. Consolidated gross margin improved to 37.1%, helped by better mix and pricing in Branded Products, while Healthcare Apparel margins softened slightly and Contact Centers margins declined.
EBITDA rose to $4.8 million from $3.5 million as higher gross profit and lower interest expense offset higher selling and administrative costs in Healthcare Apparel, including $1.0 million of severance. Operating cash flow improved to $9.4 million, aided by lower accounts receivable, and cash ended at $23.2 million. Total debt declined to $87.3 million, and the company remained in compliance with credit facility covenants while continuing dividends and share repurchases.
Superior Group of Companies (SGC) reported softer Q3 2025 results. Net sales were $138.5 million versus $149.7 million a year ago, and net income was $2.7 million versus $5.4 million. Diluted EPS was $0.18. The consolidated gross margin rate was 38.3% compared to 40.4% last year.
All three segments declined year over year: Branded Products net sales were $85.1 million (down $7.5 million), Healthcare Apparel $31.5 million (down $1.5 million), and Contact Centers $22.7 million (down $2.4 million). EBITDA was $7.5 million versus $11.7 million. The company cited timing of orders, customer mix, and macro headwinds, including the closure of its Jamaica contact center.
On the balance sheet, total debt was $100.0 million, including a $40.0 million revolver and a $60.5 million term loan, with a 5.4% weighted average interest rate as of September 30, 2025. Inventory was $105.7 million. Cash dividends were $0.14 per share in the quarter. Shares outstanding were 15,968,792 as of October 30, 2025. Management noted tariff exposures and the expiration of certain U.S. trade preferences as continuing risks.